Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 421,026 | 337,277 | 286,630 | 276,371 | 248,997 |
| Cost of Goods | 106,712 | 86,845 | 87,915 | 110,104 | 71,837 |
| Gross Profit | 314,314 | 250,432 | 198,715 | 166,267 | 177,160 |
| Operating Expenses | 304,546 | 235,362 | 224,567 | 198,395 | 168,542 |
| Operating Income | 10,480 | 15,915 | -24,937 | -32,024 | 9,455 |
| Interest Expense | 23,628 | 21,949 | 18,047 | 7,061 | 7,725 |
| Other Income | 2,400 | 5,609 | 513 | 1,241 | 390 |
| Pre-tax Income | -10,748 | -425 | -42,471 | -37,844 | 2,120 |
| Income Tax | 268 | 46 | 140 | 105 | 264 |
| Net Income Continuous | -11,016 | -471 | -42,611 | -37,949 | 1,856 |
| Net Income | $-11,016 | $-471 | $-42,611 | $-37,949 | $1,856 |
| EPS Basic Total Ops | -0.27 | -0.01 | -1.07 | -1.02 | 0.05 |
| EPS Basic Continuous Ops | -0.27 | -0.01 | -1.07 | -1.02 | 0.05 |
| EPS Diluted Total Ops | -0.27 | -0.01 | -1.07 | -1.02 | 0.04 |
| EPS Diluted Continuous Ops | -0.27 | -0.01 | -1.07 | -1.02 | 0.04 |
| EPS Diluted Before Non-Recurring Items | 0.86 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $45,509 | $43,469 | $567 | $-14,538 | $25,513 |